Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma

Cancer

Volumn 79, Issue 3, 1997, Pages 462-467

  Cho, Jae Yong ^a   Kim, Joo Hang ^a   Lee, Yi Hyeong ^c   Chung, Kyung Young ^b   Kim, Sung Kyu ^a   Gong, Soo Jung ^a   You, Nae Choon ^a   Chung, Hyun Cheol ^a   Roh, Jae Kyung ^a   Kim, Byung Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

K ras mutation; nonsmall cell lung carcinoma; prognosis; tumor progression

Indexed keywords

ARTICLE; CANCER RISK; CANCER SURVIVAL; CORRELATION FUNCTION; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE K RAS; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DNA PROBES; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0010973499     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970201)79:3<462::AID-CNCR6>3.0.CO;2-K     Document Type: Article

References (27)

1. Minna JD, Pass H, Glatstein E, Ihde DC. Lung cancer. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer:principles and practice of oncology. Philadelphia: J.B. Lippincott, 1989;591-705.
2. Choi JH, Chung HC, Yoo NC, Lee HR, Lee KH, Choi W, et al. Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea:a hospital based study Lung Cancer 1994;10:287-96.
3. Barbacid M. ras genes. Annu Rev Biochem 1987;56:779-827.
4. Bos J. ras oncogene in human cancer: a review. Cancer Res 1989;49:4682-9.
5. Mitsudomi T, Viallet J, Linnoila RI, Mulshine JL, Minna JD, Gazdar AF. Mutations of ras gene distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer lines. Oncogene 1991;6:1353-62.
6. Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymphnode metastasis. Cancer Res 1992;52:2902-6.
7. Rodenhuis S, Slebos RJ. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992;52:2665s-9s.
8. Rodenhuis S, van de Wetering M, Mooi W, Evers S, van Zandwijk N, Bos J. Mutational activation of the K-ras oncogene:a possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987;317:929-35.
9. Rodenhuis S, Slebos R, Boot A, Evers S, Mooi W, Wagenaar S, et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 1988;48:5738-41.
10. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformational polymorphism analysis of polymerase chain reaction products. Oncogene 1990;5:1037-43.
11. Slebos RJC, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJL, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990;323:561-5.
12. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 1989;5:874-9.
13. Davis L, Kuehl M, Battery J. Basic methods in molecular biology. 2nd edition. Norwalk: Appleton and Lange, 1994.
14. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-25.
15. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
16. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
17. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
18. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
19. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, Van Boom JH, Van der Eb AJ, et al. Prevalence of ras mutations in human colorectal cancers. Nature 1987;327:293-7.
20. Reddel RR, Ke Y, Kaighn ME, Malan-Shibley L, Lechner JF, Rhim JS, et al. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras:altered response to inducers of terminal squamous differentiation. Oncogene Res 1988;3:401-8.
21. Muschel RJ, Williams JE, Lowy DR, Liotta LA. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J Pathol 1985;121:1-8.
22. Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cell to ionizing radiation. Science 1988;239:645-7.
23. Sklar MD. Increased resistance to cis-diamminedichloro-platinum(II) in NIH 3T3 cells transformed by ras oncogenes. Cancer Res 1988;48:793-7.
24. Orita M, Sekiya T, Hayashi K. DNA sequence polymorphism in allele repeats. Genomics 1990;8:271-8.
25. Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 1995;55:1444-7.
26. Schafer WR, Kim R, Sterne R. Genetic and pharmacologic suppression of oncogenic mutations in ras genes of yeast and humans. Science 1989;245:379-85.
27. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K-ras expression and tumorigenecity of lung cancer cells by antisense RNA. Cancer Res 1991;51:1744-8.